Menu Menu

ABT    Abbott Laboratories    1800    
Income Statement
Revenue 44,328,000,000
Net Income 6,524,000,000
Profit Margin 14.72%

Balance Sheet
Current Assets 25,996,000,000
Assets 86,713,000,000
Current Liabilities 16,496,000,000
Equity 52,771,000,000
Shares Out 1,741,657,000

Cash Flow Statement
Operating Cash Flow 9,566,000,000
Investing Cash Flow -2,422,000,000

Market Analysis
Market Cap 159,344,700,497
Price 91.70
BVPS 30.30
PB 3.03
EPS 3.59
PE 25.54
PS 0.90
FCF 7,144,000,000
Dividends
Dividend Amount 0.55   
Dividend Yield 1.85%
Jan Feb Mar
Ex: 1/11 Pay: 2/15
Apr May Jun
Ex: 4/12 Pay: 5/15
Jul Aug Sep
Ex: 7/15 Pay: 8/15
Oct Nov Dec
Ex: 10/15 Pay: 11/15

Earnings
Jan Feb Mar
1/24 1.19 2/20 3.73
Apr May Jun
4/17 0.98
Jul Aug Sep
7/18 1.14
Oct Nov Dec
10/16 1.21

Find a discrepancy? The most accurate way to find company fundamental data is to view ABT documents filed with the SEC.


ABT Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: